HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Investigation of leukotriene involvement in the vasopermeability response associated with guinea pig tracheal anaphylaxis: comparison with cutaneous anaphylaxis.

Abstract
A direct comparison of the role of leukotrienes in mediating the increase in microvascular permeability associated with guinea pig tracheal and cutaneous anaphylaxis was obtained by simultaneous administration of inflammatory stimuli to both trachea and ear. The SRS-A antagonist, FPL 55712, reduced the increase in tracheal extravascular albumin content evoked by LTC4, LTD4, and LTE4 but failed to significantly reduce the tracheal microvascular permeability response associated with local anaphylaxis. Moreover, the inhibitory effect of the histamine H1-receptor antagonist, mepyramine, was not augmented by the additional presence of FPL 55712. In contrast to tracheal anaphylaxis, a distinct leukotriene component was indicated in cutaneous anaphylaxis since the mepyramine-FPL 55712 combination produced a greater inhibition than mepyramine alone. These results suggest that the degree of leukotriene involvement in anaphylaxis may vary between tissues.
AuthorsD F Woodward, M A Wasserman, B M Weichman
JournalEuropean journal of pharmacology (Eur J Pharmacol) Vol. 93 Issue 1-2 Pg. 9-19 (Sep 16 1983) ISSN: 0014-2999 [Print] Netherlands
PMID6313400 (Publication Type: Journal Article)
Chemical References
  • Chromium Radioisotopes
  • Chromones
  • SRS-A
  • Leukotriene E4
  • Histamine
  • FPL 55712
  • Ovalbumin
  • Pyrilamine
Topics
  • Anaphylaxis (physiopathology)
  • Animals
  • Capillary Permeability
  • Chromium Radioisotopes
  • Chromones (pharmacology)
  • Female
  • Guinea Pigs
  • Histamine (pharmacology)
  • In Vitro Techniques
  • Leukotriene E4
  • Ovalbumin
  • Passive Cutaneous Anaphylaxis (drug effects)
  • Pyrilamine (pharmacology)
  • SRS-A (analogs & derivatives, physiology)
  • Time Factors
  • Trachea (blood supply)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: